PDS Biotechnology Corp Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
PDS Biotechnology Corp quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • PDS Biotechnology Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2023 was $239K, a 18.8% decline from 2022.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2022 was $295K, a 72.7% increase from 2021.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2021 was $171K, a 74.1% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$89.1K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $89.1K +$46.1K +107% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $43K +$988 +2.35% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $42.1K +$42.1K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $0 -$49.3K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $49.3K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.